我们应用弥可保注射液(卫材苏州制药有限公司产品)穴位注射治疗糖尿病性神经病变(DPN),取得较好疗效,现报告如下:1对象和方法1·1对象本组87例DPN患者,男52例,女35例,年龄20~84岁,糖尿病史4~20年,肢体疼痛时间1个月~4年,其中1型糖尿病31例,2型糖尿病56例,应用胰岛素者45例,口服 We use acyclopamycin injection (Eisai Suzhou Pharmaceutical Co., Ltd. products) point injection treatment of diabetic neuropathy (DPN), and achieved good results, are as follows: 1 Subjects and methods 1.1 objects 87 DPN patients in this group , 52 males and 35 females, aged 20 to 84 years old, history of diabetes 4 to 20 years, limb pain for 1 month to 4 years, of which 31 cases of type 1 diabetes mellitus, 56 cases of type 2 diabetes mellitus, 45 cases of insulin ,oral